NAD+ vs SS-31: Complete 2026 Comparison
Side-by-side comparison of NAD+ and SS-31: mechanism, common use cases, dosing protocols from named experts, vendor availability, and expert opinion. Both are framed as research compounds.
TL;DR Table
| Factor | NAD+ | SS-31 |
|---|---|---|
| Class | SUPPLEMENT | PEPTIDE |
| Aliases | ["NAD plus", "nicotinamide adenine dinucleotide"] | ["Elamipretide (likely)"] |
| Mechanism | n/a | n/a |
| What it's researched for | Antioxidant cofactor used subq to prevent oxidative stress, DNA damage and brain damage. | Stabilizes the inner mitochondrial membrane, prevents oxidative stress from leaky mitochondria, and may protect kidneys against steroid-induced damage. |
| Dosing mentions tracked | 30 | 62 |
| Vendor recs tracked | 11 | 17 |
| PubMed papers | 8 | 8 |
Mechanism Comparison
What Each is Researched For
NAD+ research areas
Antioxidant cofactor used subq to prevent oxidative stress, DNA damage and brain damage.
SS-31 research areas
Stabilizes the inner mitochondrial membrane, prevents oxidative stress from leaky mitochondria, and may protect kidneys against steroid-induced damage.
Dosing Mention Comparison
NAD+ dosing
- Steve: Steve reported using 20 mg NAD+ subcutaneously daily (anecdotal, source RiV6aXNzdXY). (00:00:20)
- Narrator: Subcutaneous injections using a small needle into fat tissue; no specific dose or frequency stated. Speaker contrasts this with... (00:00:38)
- Steve: Injectable NAD+ IV or SubQ; also available in injectable pre-workout formulations (00:02:33)
- Speaker: Injectable NAD+ reported preferably via IV route, with SubQ or IM administration also documented - paired with 5-amino-1MQ (00:03:00)
- Host: The host reported using: IV 100 mg to 200 mg once weekly, OR 25 mg to 50 mg IM/SubQ multiple times per week (00:03:35)
SS-31 dosing
- VigorousSteve: 2 mg to 40 mg daily for mitochondrial/oxidative stress protection (00:02:06)
- Vigorous Steve: Vigorous Steve reported a dosing range of 2 mg to 40 mg daily being discussed in the context of oxidative stress and mitochondrial... (00:02:06)
- Vigorous Steve: Vigorous Steve reported anecdotal use of SS-31 at 2 mg to 40 mg daily for oxidative stress and mitochondrial protection support. (00:02:06)
- Vigorous Steve: Maintenance: 1-2 mg/day; Healing: 5-10 mg/day; Full medical dose: 40 mg/day (00:07:38)
- Steve: Steve reported (anecdotal, source iQ9JgQV-VRo) a maintenance range of 1-2 mg/day, a healing range of 5-10 mg/day, and a full... (00:07:40)
Side Effect Notes
Anecdotal reports for both compounds vary by route, dose, and individual. Neither should be treated as an approved medication. Consult a qualified clinician.
When To Choose Which
Comparison depends on research question, available source quality, and individual risk tolerance. See the full profiles for NAD+ and SS-31 for context-specific details.
Can You Stack Them?
Stacking decisions should be evaluated by qualified professionals with attention to dose attribution, source quality, and outcome tracking. This page is a research aggregator and does not recommend stacking protocols.
FAQ
Which has more research?
NAD+ has 8 PubMed citations indexed; SS-31 has 8.
Which has more vendor coverage?
NAD+: 11 tracked vendor recommendations. SS-31: 17.
Are they approved drugs?
Both are framed on this site as research compounds. Verify current FDA status and state-specific rules before any decision.